Turnbull Biotech ApS: Financial statements 2025
CVR: 43491938
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Turnbull Biotech ApS (CVR 43491938) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -71,508 and a net result of DKK -241,233 compared with DKK 166,587 the year before. Equity in the 2025 report amounted to DKK 251,823. The solvency ratio was 90.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -71,508
- Profit/Loss
- DKK -241,233
- Equity
- DKK 251,823
- Total Assets
- DKK 279,295
- Employees
- 1
Official annual report
How creditworthy is Turnbull Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Turnbull Biotech ApS has published its annual report for 2024. Gross profit came to DKK -51,241, and the net result was DKK 166,587.
About Turnbull Biotech ApS
Turnbull Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jordan Philip Turnbull. The company is owned by Jordan Philip Turnbull. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -71,508 and a net result of DKK -241,233 compared with DKK 166,587 the year before. Equity in the 2025 report amounted to DKK 251,823.
